investor.medpace.com
Overview | Investors | MedpaceMedpace Inc. is a clinical research organization and drug and medical device development service, critical to the advancement of global clinical trials.
http://investor.medpace.com/
Medpace Inc. is a clinical research organization and drug and medical device development service, critical to the advancement of global clinical trials.
http://investor.medpace.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
0.7 seconds
16x16
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
83
SITE IP
23.215.102.32
LOAD TIME
0.672 sec
SCORE
6.2
Overview | Investors | Medpace | investor.medpace.com Reviews
https://investor.medpace.com
Medpace Inc. is a clinical research organization and drug and medical device development service, critical to the advancement of global clinical trials.
Bioanalytical Laboratory Services | Medpace
http://www.medpace.com/WhatWeDo/Laboratories/BioanalyticalLaboratories/BioanalyticalLab.aspx?a=BioanalyticalLaboratories
Infectious Disease and Vaccines. Rare and Orphan Disease. Clinical Trial Management System. Interactive Voice/Web Response System. Laboratory Information Management System. Data Management / Electronic Data Capt. Want to learn more about our bioanalytical laboratory capabilities? Simply fill out this form and we will contact you. Early Phase Clinical Development. Fact Sheet: Medpace Bioanalytical Laboratories. Fact Sheet: Medpace Clinical Pharmacology Unit. Led by an executive management team that averag...
Your new career adventure awaits at Medpace CRO
http://www.medpace.com/Careers/WhyMedpace/Default.aspx
Infectious Disease and Vaccines. Rare and Orphan Disease. Clinical Trial Management System. Interactive Voice/Web Response System. Laboratory Information Management System. Data Management / Electronic Data Capt. We are intensely committed to quality and the principles of Good Clinical Practice. We recognize collaboration is key to our success and communicate in a complete, concise, and accurate manner. We recruit and hire people who have a track record of success. Medpace participates in E-Verify.
Biometrics | Medpace
http://www.medpace.com/WhatWeDo/Biometrics/Default.aspx?a=Biometrics
Infectious Disease and Vaccines. Rare and Orphan Disease. Clinical Trial Management System. Interactive Voice/Web Response System. Laboratory Information Management System. Data Management / Electronic Data Capt. Study Participant Sign-up Form. Learn More About Medical Research. How Are Participants Chosen. Want to learn more about the Medpace Biometrics team? Simply fill out this form and we will contact you. Led by scientific and technical experts, the Medpace Biometrics team has the clinical data mana...
Regulatory Affairs | Medpace
http://www.medpace.com/WhatWeDo/RegulatoryAffairs/Default.aspx?a=RegulatoryAffairs
Infectious Disease and Vaccines. Rare and Orphan Disease. Clinical Trial Management System. Interactive Voice/Web Response System. Laboratory Information Management System. Data Management / Electronic Data Capt. Study Participant Sign-up Form. Learn More About Medical Research. How Are Participants Chosen. Want to learn more about our expertise in Regulatory Affairs? Simply fill out this form and we will contact you. Fact Sheet: Regulatory Publishing (PDF). Medpace has developed and maintains Electronic...
Imaging Core Laboratory | Medpace
http://www.medpace.com/WhatWeDo/Imaging/Default.aspx?a=ImagingCoreLab
Infectious Disease and Vaccines. Rare and Orphan Disease. Clinical Trial Management System. Interactive Voice/Web Response System. Laboratory Information Management System. Data Management / Electronic Data Capt. Medical Imaging Core Laboratory. Want to learn more about our Imaging Core Lab? Simply fill out this form and we will contact you. Fact Sheet: Imaging Core Lab Summary (PDF). Article: Medpace Provides Full Service Support for Anamorelin Phase III Study Download Article Published in Lancet Oncol.
What We Do | Medpace
http://www.medpace.com/WhatWeDo/Default.aspx?a=Services
Infectious Disease and Vaccines. Rare and Orphan Disease. Clinical Trial Management System. Interactive Voice/Web Response System. Laboratory Information Management System. Data Management / Electronic Data Capt. Study Participant Sign-up Form. Learn More About Medical Research. How Are Participants Chosen. Want to learn more about our customized services? Simply fill out this form and we will contact you. To create a customized approach that ensures powerful solutions for our partners around the globe.
Medical Device Overview | Medpace
http://www.medpace.com/WhatWeDo/Device/Default.aspx?a=Overview
Infectious Disease and Vaccines. Rare and Orphan Disease. Clinical Trial Management System. Interactive Voice/Web Response System. Laboratory Information Management System. Data Management / Electronic Data Capt. Clinical and Regulatory Strategy. Want to learn more about the Medpace difference for medical device studies? Simply fill out this form and we will contact you. Blaine, MN 55014 USA. Tel: 1.612.234.8500. Fax: 1.612.234.8501. Medpace Medical Device B.V. NL 6291 EN Vaals. Fact Sheet: MMD Overview.
The Power of X in Clinical Trials: eXperts, eXperience, eXecution
http://www.medpace.com/PowerX/Full-ServiceCRO.aspx
Infectious Disease and Vaccines. Rare and Orphan Disease. Clinical Trial Management System. Interactive Voice/Web Response System. Laboratory Information Management System. Data Management / Electronic Data Capt. Experts Experience Execution = A Powerful Combination that DELIVERS Results. Please enter the security code. Find out how our medical, regulatory, and operational expertise in drug and medical device clinical development can help with your next study or program. Therapeutic Global Phase I thru IV.
Therapeutically Specialized CRO | Medpace
http://www.medpace.com/OurExpertise/Default.aspx?a=TherapeuticExperience
Infectious Disease and Vaccines. Rare and Orphan Disease. Clinical Trial Management System. Interactive Voice/Web Response System. Laboratory Information Management System. Data Management / Electronic Data Capt. Therapeutically Specialized Clinical Research. Infectious Disease and Vaccines. Rare and Orphan Disease. Find out how our clinical research expertise in drug and medical device can help with your next study or program. Streamline and Accelerate your Clinical Trials. Medpace has perfected a disci...
TOTAL LINKS TO THIS WEBSITE
83
MCOT
Management Discussion and Analysis. Corporate Governance Committee Charter. Charter, Criteria and Guidelines for Directors. Ad Hoc Committee Charter. Criteria and Guidelines for Directors of Subsidiary Company, Joint Venture Company, and Joint Operations Company. Good Corporate Governance Policy. Announcement On Anti-Corruption Policy. Certificate of ESG100 Company. Guideline for Stakeholder Engagement. Policy on Safety, Occupational Health and Working Environment. Code of Conduct and Ethics. Keep yourse...
Investor Relations | Medidata Solutions, Inc.
Skip to main navigation. Stock Quote and Chart. Annual Reports and Proxies. Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives. How Do Technology and Data Accelerate Precision Medicine in Oncology? Industry Experts to Discuss During Medidata Webinar. 1 917 522 4620. How may we help you?
Investor Relations | MDU Resources Group, Inc.
Skip to main navigation. MDU Resources Group, Inc., a member of the S&P MidCap 400 index and the S&P High-Yield Dividend Aristocrats index, provides essential products and services through its regulated energy delivery and construction materials and services businesses. Asset-based natural resource company. Solid balance sheet with equity of 59% of total capital at Dec. 31. 80 consecutive years of uninterrupted quarterly common stock dividend payments. Member of S&P MidCap 400 Index. Mar 29, 2018.
Investor.me - Email and Direct Mail Lists for Investor Relations (IR) Marketers
Welcome to Investor.me! Are you are an Email or Direct Mail Marketer of Investment Services, Investment Newsletters, Money Management Services, Investment Seminars, or Investor Relations (IR) type offers? If so, we have targeted lists. That will get your specific message into the hands of individual investors who are looking for information and advice to build their personal wealth with stocks. Are you ready to get started? If so, send an email by. Oil, Gas and Energy. That reach active investors:.
MedImmune | Investors | Investor Relations Home
MedImmune is part of the AstraZeneca group of companies. Please direct all investor relations inquiries to AstraZeneca. To access investor relations information on AstraZeneca's website. Maryland Regional Biotech Forum Aims to Propel Washington, D.C. Metro Region to a Top Three Ranked U.S. Biotech Hub by 2023. MedImmune Presents Promising New Data in Systemic Lupus at American College of Rheumatology Meeting.
Overview | Investors | Medpace
Infectious Disease and Vaccines. Rare and Orphan Disease. Clinical Trial Management System. Interactive Voice/Web Response System. Laboratory Information Management System. Data Management / Electronic Data Capt. Medpace Holdings, Inc. Cincinnati, OH 45227. Date as of 01/12/17 10:12 am ET. Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources. November 3, 2016. Medpace Holdings, Inc. Reports Third Quarter 2016 Results. October 24, 2016. October 17, 2016.
MEI Pharma - Investors
Aug 4, 2015. MEI Pharma to Present at Wedbush PacGrow Healthcare Conference. Jul 1, 2015. MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference. Jun 12, 2015. MEI Pharma Reports Updated Results from Phase II Study of Pracinostat and Azacitidine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia. May 6, 2015. MEI Pharma to Present at Bank of America Merrill Lynch Health Care Conference. Wedbush PacGrow Healthcare Conference Presentation. Vice President, Investor Relations.
Investor Relations - Memorial Production Partners LP
Environmental Health & Safety. Memorial Production Partners LP is an upstream Master Limited Partnership (MLP) focused on the acquisition, production and development of oil and gas properties in the United States. Our properties consist of mature, legacy oil and natural gas fields. Our primary business objective is to generate stable cash flows, allowing us to make quarterly cash distributions to our unitholders and, over time, to increase those quarterly cash distributions. Unit data, history.
Mencast Holdings - Investor Relations: Mencast Holdings IR
This website is best viewed in 1200x768 pixels screen resolution and above. Comprehensive MRO Solutions Provider in the Offshore, Marine and Oil and Gas Industries. At present, our Group services our customers through its three business segments, being Offshore and Engineering, Marine, and Energy Services. Welcome to the Mencast Newsroom. Here you'll find our latest news releases, press releases, events and our financial news. Welcome to Mencast Holdings Investor Relations. We keep economies moving.
Investor Relations | Mercadolibre, Inc.
Skip to main navigation. Mercado Libre - Donde comprás y vendés de todo. Annual Reports and SEC. Annual Reports and SEC. Feb 22, 2018. MercadoLibre, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results. Feb 15, 2018. MercadoLibre, Inc. to Report Fourth Quarter 2017 Financial Results. Nov 2, 2017. MercadoLibre, Inc. Reports Third Quarter Financial Results. 742 million Sold Items, up 55.8%, 62.3 million Total Payment Transactions, up 69.4% Net Revenues of $370.7 million , growin...
Mercury Insurance | Save money on your auto insurance and more with Mercury
How to File a Claim. Login to Your Account. Make a One-Time Payment. Low Rates and Incredible Service. Get a Fast, Free Quote. Or call us at (800) 882-9121. Retrieve a Saved Quote. Prefer to talk to a real, live person? Give us a call at (800) 956-3728. Low Rates and Incredible Service. Get an auto insurance quote and buy your policy online. MAKE A ONE-TIME PAYMENT. Find an Agent Near You. Let a Mercury agent do the work for you. Just enter your zip code or browse agents by state. News You Can Use. A com...
SOCIAL ENGAGEMENT